BR0210424A - Derivados de ácidos dicarboxìlicos aromáticos - Google Patents
Derivados de ácidos dicarboxìlicos aromáticosInfo
- Publication number
- BR0210424A BR0210424A BR0210424-5A BR0210424A BR0210424A BR 0210424 A BR0210424 A BR 0210424A BR 0210424 A BR0210424 A BR 0210424A BR 0210424 A BR0210424 A BR 0210424A
- Authority
- BR
- Brazil
- Prior art keywords
- dicarboxylic acid
- acid derivatives
- aromatic dicarboxylic
- compounds
- report
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
"DERIVADOS DE áCIDOS DICARBOXìLICOS AROMáTICOS". A presente invenção refere-se a compostos de fórmula (1) em que A, R1 e R2 possuem o significado definido no relatório, processo de fabricação destes compostos e medicamentos com atividade inibidora de HDAC contendo tais compostos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01114496 | 2001-06-15 | ||
PCT/EP2002/006488 WO2003011851A2 (en) | 2001-06-15 | 2002-06-13 | Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0210424A true BR0210424A (pt) | 2004-08-17 |
Family
ID=8177731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0210424-5A BR0210424A (pt) | 2001-06-15 | 2002-06-13 | Derivados de ácidos dicarboxìlicos aromáticos |
Country Status (33)
Country | Link |
---|---|
US (2) | US6784173B2 (pt) |
EP (1) | EP1401824B1 (pt) |
JP (1) | JP4195377B2 (pt) |
KR (2) | KR20090059172A (pt) |
CN (1) | CN1271066C (pt) |
AR (1) | AR036055A1 (pt) |
AT (1) | ATE343569T1 (pt) |
AU (1) | AU2002355626B2 (pt) |
BG (1) | BG108450A (pt) |
BR (1) | BR0210424A (pt) |
CA (1) | CA2449804A1 (pt) |
CO (1) | CO5540280A2 (pt) |
CZ (1) | CZ200425A3 (pt) |
DE (1) | DE60215652T2 (pt) |
EC (1) | ECSP034896A (pt) |
ES (1) | ES2272800T3 (pt) |
GT (1) | GT200200121A (pt) |
HK (1) | HK1065787A1 (pt) |
HR (1) | HRP20031019A2 (pt) |
HU (1) | HUP0401233A3 (pt) |
IL (1) | IL159097A0 (pt) |
MA (1) | MA27041A1 (pt) |
MX (1) | MXPA03011501A (pt) |
NO (1) | NO20035555D0 (pt) |
NZ (1) | NZ529874A (pt) |
PA (1) | PA8548001A1 (pt) |
PE (1) | PE20030086A1 (pt) |
PL (1) | PL366729A1 (pt) |
RS (1) | RS98203A (pt) |
RU (1) | RU2289580C2 (pt) |
SK (1) | SK172004A3 (pt) |
WO (1) | WO2003011851A2 (pt) |
ZA (1) | ZA200309260B (pt) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
EP1485348B1 (en) | 2002-03-13 | 2008-06-11 | Janssen Pharmaceutica N.V. | Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
EA007272B1 (ru) * | 2002-03-13 | 2006-08-25 | Янссен Фармацевтика Н. В. | Новые ингибиторы гистондеацетилазы |
ATE399012T1 (de) * | 2002-04-03 | 2008-07-15 | Topotarget Uk Ltd | Carbaminsäurederivate enthaltend eine piperazin verknüpfung als hdac-inhibitoren |
US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
TW200418825A (en) * | 2002-12-16 | 2004-10-01 | Hoffmann La Roche | Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives |
TW200424174A (en) * | 2003-02-06 | 2004-11-16 | Hoffmann La Roche | New TP diamide |
US7208491B2 (en) * | 2003-02-07 | 2007-04-24 | Hoffmann-La Roche Inc. | N-monoacylated o-phenylenediamines |
KR20050122210A (ko) | 2003-03-17 | 2005-12-28 | 다케다 샌디에고, 인코포레이티드 | 히스톤 탈아세틸화 효소 억제제 |
TW200424187A (en) * | 2003-04-04 | 2004-11-16 | Hoffmann La Roche | New oxime derivatives and their use as pharmaceutically active agents |
CA2542096A1 (en) * | 2003-10-09 | 2005-04-21 | Aton Pharma, Inc. | Thiophene and benzothiophene hydroxamic acid derivatives |
US20050159470A1 (en) * | 2003-12-19 | 2005-07-21 | Syrrx, Inc. | Histone deacetylase inhibitors |
WO2005066151A2 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7217723B2 (en) | 2004-02-02 | 2007-05-15 | Eisai Co., Ltd. | Heterocyclic compound having oxime group |
US20050203081A1 (en) * | 2004-02-25 | 2005-09-15 | Jinbo Lee | Inhibitors of protein tyrosine phosphatase 1B |
AR047894A1 (es) * | 2004-02-25 | 2006-03-01 | Wyeth Corp | Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b |
CA2566515A1 (en) * | 2004-06-14 | 2005-12-22 | F. Hoffmann-La Roche Ag | Thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
CA2566525A1 (en) * | 2004-06-14 | 2005-12-22 | F. Hoffmann-La Roche Ag | Thiophene derivatives, their manufacture and use as pharmaceutical agents |
US7638553B2 (en) | 2004-06-14 | 2009-12-29 | Hoffmann-La Roche Inc. | Hydroxamates, their manufacture and use as pharmaceutical agents |
EP1781639B1 (en) | 2004-07-28 | 2012-01-25 | Janssen Pharmaceutica NV | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
KR100620488B1 (ko) | 2004-08-13 | 2006-09-08 | 연세대학교 산학협력단 | 신규한 히스톤 디아세틸라아제 억제제 및 이의 제조방법 |
US7642275B2 (en) * | 2004-12-16 | 2010-01-05 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
WO2006094068A2 (en) * | 2005-03-01 | 2006-09-08 | The Regents Of The University Of Michigan | Hdac inhibitors that promote brm expression and brm related diagnostics |
US20100087328A1 (en) * | 2005-03-01 | 2010-04-08 | The Regents Of The University Of Michigan | Brm expression and related diagnostics |
JP2008536925A (ja) * | 2005-04-20 | 2008-09-11 | メルク エンド カムパニー インコーポレーテッド | ベンゾチオフェンヒドロキサム酸誘導体 |
GB0509225D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Inhibitors of enzymatic activity |
GB0509223D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
EP1896436A2 (en) * | 2005-05-11 | 2008-03-12 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
CN101263121A (zh) * | 2005-07-14 | 2008-09-10 | 塔克达圣地亚哥公司 | 组蛋白脱乙酰基酶抑制剂 |
GB0518237D0 (en) * | 2005-09-07 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
AR057579A1 (es) * | 2005-11-23 | 2007-12-05 | Merck & Co Inc | Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac) |
EP1963262A2 (en) * | 2005-12-15 | 2008-09-03 | Vicuron Pharmaceuticals, Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
EP1976835A2 (en) * | 2006-01-13 | 2008-10-08 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
CN101370790B (zh) | 2006-01-19 | 2015-10-21 | 詹森药业有限公司 | 作为组蛋白去乙酰化酶抑制剂的吡啶和嘧啶衍生物 |
GB0603041D0 (en) * | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
GB0619753D0 (en) | 2006-10-06 | 2006-11-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
BRPI0622100A2 (pt) | 2006-10-30 | 2011-12-27 | Chroma Therapeutics Ltd | hidroxamatos como inibidores de desacetilase de histona |
GB0713686D0 (en) * | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
WO2009045385A1 (en) * | 2007-10-04 | 2009-04-09 | Merck & Co., Inc. | N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors |
EP2330894B8 (en) | 2008-09-03 | 2017-04-19 | BioMarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors |
GB0903480D0 (en) | 2009-02-27 | 2009-04-08 | Chroma Therapeutics Ltd | Enzyme Inhibitors |
DK2680694T3 (en) | 2011-02-28 | 2019-03-25 | Biomarin Pharm Inc | HISTONDEACETYLASE INHIBITORS |
US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
AU2014228344C1 (en) | 2013-03-15 | 2019-02-07 | Biomarin Pharmaceutical Inc. | HDAC inhibitors |
EP2826769A1 (en) | 2013-07-18 | 2015-01-21 | Institut de Recherche pour le Développement ( IRD) | Compounds for the treatment and/or prevention of parasitic diseases and method of production thereof |
KR101536050B1 (ko) * | 2013-07-30 | 2015-07-13 | 충북대학교 산학협력단 | 신규 이사틴 기반 히드록삼산 및 이를 유효성분으로 포함하는 항암용 조성물 |
EP3769757A3 (en) * | 2013-10-18 | 2021-10-06 | The General Hospital Corporation | Imaging histone deacetylases with a radiotracer using positron emission tomography |
MX2016011833A (es) | 2014-03-12 | 2017-03-29 | Chong Kun Dang Pharmaceutical Corp | Nuevos compuestos como inhibidores de histona desacetilasa 6 y composiciones farmaceuticas que los comprenden. |
WO2019185413A1 (en) | 2018-03-27 | 2019-10-03 | Basf Se | Pesticidal substituted cyclopropyl derivatives |
WO2024123700A1 (en) * | 2022-12-05 | 2024-06-13 | The General Hospital Corporation | Histone deacetylase inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3825554A (en) * | 1969-06-13 | 1974-07-23 | Atlantic Richfield Co | Method for preparing cyclic nitrile carbonates |
JPS54148743A (en) * | 1978-05-12 | 1979-11-21 | Asahi Chem Ind Co Ltd | Production of methoclopramide |
US5700811A (en) * | 1991-10-04 | 1997-12-23 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and method of use thereof |
US5369108A (en) * | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
AUPO721997A0 (en) | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
US6541661B1 (en) | 1999-11-23 | 2003-04-01 | Methylgene, Inc. | Inhibitors of histone deacetylase |
-
2002
- 2002-06-11 US US10/167,677 patent/US6784173B2/en not_active Expired - Fee Related
- 2002-06-12 PA PA20028548001A patent/PA8548001A1/es unknown
- 2002-06-13 NZ NZ529874A patent/NZ529874A/xx unknown
- 2002-06-13 IL IL15909702A patent/IL159097A0/xx unknown
- 2002-06-13 ES ES02791436T patent/ES2272800T3/es not_active Expired - Lifetime
- 2002-06-13 AT AT02791436T patent/ATE343569T1/de not_active IP Right Cessation
- 2002-06-13 MX MXPA03011501A patent/MXPA03011501A/es active IP Right Grant
- 2002-06-13 RU RU2003137578/04A patent/RU2289580C2/ru not_active IP Right Cessation
- 2002-06-13 AU AU2002355626A patent/AU2002355626B2/en not_active Ceased
- 2002-06-13 SK SK17-2004A patent/SK172004A3/sk unknown
- 2002-06-13 CN CNB028120108A patent/CN1271066C/zh not_active Expired - Fee Related
- 2002-06-13 CA CA002449804A patent/CA2449804A1/en not_active Abandoned
- 2002-06-13 CZ CZ200425A patent/CZ200425A3/cs unknown
- 2002-06-13 PL PL02366729A patent/PL366729A1/xx not_active Application Discontinuation
- 2002-06-13 HU HU0401233A patent/HUP0401233A3/hu unknown
- 2002-06-13 JP JP2003517043A patent/JP4195377B2/ja not_active Expired - Fee Related
- 2002-06-13 BR BR0210424-5A patent/BR0210424A/pt not_active IP Right Cessation
- 2002-06-13 KR KR1020097010546A patent/KR20090059172A/ko not_active Application Discontinuation
- 2002-06-13 WO PCT/EP2002/006488 patent/WO2003011851A2/en active Application Filing
- 2002-06-13 AR ARP020102231A patent/AR036055A1/es unknown
- 2002-06-13 DE DE60215652T patent/DE60215652T2/de not_active Expired - Fee Related
- 2002-06-13 PE PE2002000510A patent/PE20030086A1/es not_active Application Discontinuation
- 2002-06-13 KR KR1020037016358A patent/KR100910958B1/ko not_active IP Right Cessation
- 2002-06-13 EP EP02791436A patent/EP1401824B1/en not_active Expired - Lifetime
- 2002-06-13 RS YUP-982/03A patent/RS98203A/sr unknown
- 2002-06-14 GT GT200200121A patent/GT200200121A/es unknown
-
2003
- 2003-11-27 ZA ZA200309260A patent/ZA200309260B/en unknown
- 2003-12-09 HR HR20031019A patent/HRP20031019A2/xx not_active Application Discontinuation
- 2003-12-10 CO CO03108279A patent/CO5540280A2/es not_active Application Discontinuation
- 2003-12-11 EC EC2003004896A patent/ECSP034896A/es unknown
- 2003-12-12 NO NO20035555A patent/NO20035555D0/no not_active Application Discontinuation
- 2003-12-12 MA MA27440A patent/MA27041A1/fr unknown
- 2003-12-15 BG BG108450A patent/BG108450A/xx unknown
-
2004
- 2004-05-17 US US10/847,166 patent/US20040214862A1/en not_active Abandoned
- 2004-10-29 HK HK04108497A patent/HK1065787A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210424A (pt) | Derivados de ácidos dicarboxìlicos aromáticos | |
BR0112693A (pt) | (derivados) de ácido sulfonilaminometilbenzóico substituìdos e processo para preparação do mesmo | |
CA2305313A1 (en) | Acylsulfamoylbenzamides, crop protection compositions comprising them, and processes for their preparation | |
ATE193883T1 (de) | Verbindungen und ihre zusammensetzungen mit entzündungshemmenden und anti-thrombotischen wirkungen | |
YU70901A (sh) | Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
IL176062A0 (en) | Dpp-iv inhibitors | |
BR0116402A (pt) | Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular | |
BR0317348A (pt) | EnantiÈmeros de derivados de ácido tiofeno hidroxâmico e seu uso como inibidores de hdac | |
BR0212535A (pt) | Compostos e composições como inibidores de catepsina | |
BR0008682A (pt) | 3-amino-3-arilpropan-1-ol, processo para sua produção, seu uso e medicamento | |
BR9916680A (pt) | Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina | |
UA49884C2 (uk) | ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ | |
BR9810657A (pt) | "processo de preparação de um per-hidroisoindol substituìdo" | |
BR0211903A (pt) | Isoxazolopiridinonas | |
BR0013751A (pt) | Processo para produção de derivados de ácido naftiridina-3-carboxìlico | |
BR0000901A (pt) | Derivados 4-fenil-4-heteroarilpiperidina | |
BR0211223A (pt) | Derivados de 4-aminociclohexanol substituìdos | |
BRPI0417140A (pt) | derivados quinolina ácidos e seu uso na prevenção e/ou tratamento de patologias relacionadas com hiperglicemia | |
BR9909029A (pt) | Estabilização de poliisocianatos orgânicos | |
BR0008681A (pt) | Derivados de 3-amino -3-arilpropan-1-ol, processo para sua obtenção, medicamento e seu uso | |
BR0313796A (pt) | Processo para preparação de monoalquilaminocetonas | |
UA85994C2 (en) | N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives | |
ATE399779T1 (de) | Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten | |
FI972605A0 (fi) | Myrsyraloesning med saenkt korroderande verkan | |
BG105892A (en) | Phosphoric acid salt of an aromatic diamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: C07D 333/38, A61K 31/00, C07C 259/10, C07D 409/12, C07D 213/40, C07D 317/58, C07D 295/18, C07D 211/16, C07D 307/14, C07D 207/09 Ipc: C07D 333/38 (2011.01), A61K 31/00 (2011.01), C07C |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |